Why a $5M Contrarian Bet on Azenta Could Pay Off After a 70% Drop
After a 70% slide, Azenta's lower valuation and recurring sample-management revenue make a $5M contrarian stake appealing — if operational fixes, industry demand and execution improve.
Yahoo Finance
2 min read
Stocks
Market Analysis
Biotechnology